CLINICAL TRIAL SUMMARY

MDACC Study No:2009-0775 (clinicaltrials.gov NCT No: NCT01054456)
Title:A Multicenter, Open-Label, Single-Arm Evaluation of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Who Have Experienced CINV during the Previous Cycle of Low Emetogenic chemotherapy (LEC)
Principal Investigator:Saroj Vadhan-Raj
Treatment Agent:Palonosetron
Study Status:Terminated
Study Description:The goal of this clinical research study is to learn if palonosetron can help
to control CINV. The safety of this drug will also be studied.

Hide details for General InformationGeneral Information

Disease Group:Lymphoma; Sarcoma
Phase of Study:Phase II
Treatment Agents:Palonosetron
Treatment Location:Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions
Estimated Length of Stay in Houston:N/A
Supported By:Eisai
Return Visit:3 visits
Home Care:N/A


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Saroj Vadhan-Raj
Dept:Cytokines and Supportive Care
For Clinical Trial Enrollment:713-792-7966
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults